Clinical Trial Manager

Skyhawk Therapeutics; Boston; On-site; GBP 40,000 - 70,000; Full time

Job summary

Skyhawk Therapeutics is seeking a Clinical Trial Manager to spearhead their Huntington’s Disease program. The role involves managing clinical trial operations, ensuring compliance with regulations, and leading diverse teams. Ideal candidates will possess key skills in problem-solving, organization, and effective communication, along with a strong background in Clinical Operations.

Qualifications

• Minimum of 3 years Clinical Operations experience within Pharma, Biotech, or CRO.
• Oncology/Immuno-oncology or immunology/inflammation experience required.
• Good understanding of US regulatory requirements.

Responsibilities

• Primary operational contact for study execution in compliance with regulations.
• Lead both internal and external trial management teams.
• Manage site-facing meetings and oversee the Trial Master File.

Skills

Teamwork

Organizational skills

Interpersonal skills

Problem-solving skills

Effective communication

Education

Bachelor’s degree in biomedical, life science or related field

Job description

Clinical Trial Manager

Skyhawk Therapeutics seeks a Clinical Trial Manager with relevant Clinical Operations experience to join our Clinical group and who will be responsible for providing trial management support for our Huntington’s Disease program.

Responsibilities:

• Primary operational contact for execution of the study in compliance with ICH/GCP, Regulatory Authorities' regulations/guidelines, and applicable SOPs/Work Instructions
• Development, management, maintenance of study deliverables [i.e. timelines, study plans, etc.] through collaboration with internal and external stakeholders
• Lead weekly meeting of the Clinical Trial Team on status of assigned studies.
• Proactive identification of potential risks and development/implementation of actions to avoid or mitigate
• Operational input into study documents such as synopsis, protocol, Informed Consent Forms, CRFs, CRF Completion Guidelines, Study Execution Plans, Clinical Data Review Plan, etc.
• Participation in clinical service provider (vendor) selection, specification development, and management/oversight
• Development/coordination of study training for study team, investigational sites, and vendors in collaboration with medical and scientific colleagues
• Proactive management of issues and information sharing with key internal/external stakeholders with use of standardized reports and other mechanisms.
• Lead both an internal and external/CRO trial management team, to ensure the successful conduct of the trial in accordance with State and Federal regulations, GCP regulations, ICH guidelines, and internal SOPs
• Manage and lead site-facing meetings, including regular PI meetings, dose escalation meetings, and Investigator Meetings
• Attend study site visits, such as pre-study selection visits, site initiation visits, and PI engagement meetings
• Contribute to development of proactive strategy and corrective action plan to address trial issues in collaboration with cross functional team
• Responsible for supporting the management, oversight (CRO) and maintenance of the Trial Master File (TMF)

Requirements, Education, Experience & Skills:

• Bachelor’s degree, or equivalent, in a biomedical, life science or related field of study
• Minimum of 3 years of progressively increasing Clinical Operations experience within the Pharma, Biotech or CRO industry; Oncology/Immuno-oncology or immunology/inflammation experience required
• Good understanding of US regulatory and compliance requirements for clinical research
• Solid teamwork, organizational, interpersonal, and problem-solving skills; exercises good judgment with respect to confidential information and strategies
• Can communicate effectively
• Ability to influence and collaborate well with colleagues and partners in a fast-paced environment
• Ability and willingness to travel up to 25% of time.

About Skyhawk

Skyhawk is committed to discovering, developing, and commercializing small molecule therapeutics that correct RNA splicing. We use our novel SkySTAR platform (Skyhawk Small molecule Therapeutics for Alternative splicing of RNA) to develop drug candidates directed to targets for some of the world’s most intractable diseases including cancer, neurological conditions, and other “undruggable” targets against a wide range of conditions.